Matrix‐dependent perturbation of TGFβ signaling and disease

[1]  Paul Coucke,et al.  Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD. , 2013, International journal of cardiology.

[2]  Haiwei Xu,et al.  Overexpression of Fibulin-5 in Retinal Pigment Epithelial Cells Inhibits Cell Proliferation and Migration and Downregulates VEGF, CXCR4, and TGFB1 Expression in Cocultured Choroidal Endothelial Cells , 2012, Current eye research.

[3]  S. Dooley,et al.  Fibronectin Protects from Excessive Liver Fibrosis by Modulating the Availability of and Responsiveness of Stellate Cells to Active TGF-β , 2011, PloS one.

[4]  J. Nyman,et al.  Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I. , 2011, Human molecular genetics.

[5]  N. Frangogiannis,et al.  Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.

[6]  W. Taki,et al.  Tenascin‐C enhances crosstalk signaling of integrin αvβ3/PDGFR‐β complex by SRC recruitment promoting PDGF‐induced proliferation and migration in smooth muscle cells , 2011, Journal of cellular physiology.

[7]  H. Dietz,et al.  Pravastatin Reduces Marfan Aortic Dilation , 2011, Circulation.

[8]  M. Rieder,et al.  Exome Sequencing Identifies SMAD3 Mutations as a Cause of Familial Thoracic Aortic Aneurysm and Dissection With Intracranial and Other Arterial Aneurysms , 2011, Circulation research.

[9]  S. Apte,et al.  Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function , 2011, Cellular and Molecular Life Sciences.

[10]  P. J. van der Spek,et al.  Impaired Vascular Contractility and Aortic Wall Degeneration in Fibulin-4 Deficient Mice: Effect of Angiotensin II Type 1 (AT1) Receptor Blockade , 2011, PloS one.

[11]  D. Sillence,et al.  Mutations in the TGFβ binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias. , 2011, American journal of human genetics.

[12]  M. Trojanowska,et al.  CCN2 Is Required for the TGF-β Induced Activation of Smad1 - Erk1/2 Signaling Network , 2011, PloS one.

[13]  D. Hinton,et al.  Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRII. , 2011, Investigative ophthalmology & visual science.

[14]  H. Dietz,et al.  Lessons on the pathogenesis of aneurysm from heritable conditions , 2011, Nature.

[15]  R. Lewis,et al.  SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction , 2011, American journal of medical genetics. Part A.

[16]  D. Judge,et al.  Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism , 2011, Science.

[17]  Samarjit Patnaik,et al.  Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice , 2011, Science.

[18]  R. Mecham,et al.  New insights into the pathogenesis of autosomal‐dominant cutis laxa with report of five ELN mutations , 2011, Human mutation.

[19]  D. Berg,et al.  Analysis of ACTA2 in European Moyamoya disease patients. , 2011, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[20]  Eric P Hoffman,et al.  Losartan Decreases Cardiac Muscle Fibrosis and Improves Cardiac Function in Dystrophin-Deficient Mdx Mice , 2011, Journal of cardiovascular pharmacology and therapeutics.

[21]  G. Vriend,et al.  Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis , 2011, Nature Genetics.

[22]  D. Rifkin,et al.  Long form of latent TGF‐β binding protein 1 (Ltbp1L) regulates cardiac valve development , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[23]  S. Shete,et al.  Mutations in myosin light chain kinase cause familial aortic dissections. , 2010, American journal of human genetics.

[24]  J. Schwarzbauer,et al.  Assembly of fibronectin extracellular matrix. , 2010, Annual review of cell and developmental biology.

[25]  D. Milewicz,et al.  De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction , 2010, American journal of medical genetics. Part A.

[26]  C. van Breemen,et al.  Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome. , 2010, The Journal of thoracic and cardiovascular surgery.

[27]  H. Schnaper,et al.  Loss of β1-Integrin Enhances TGF-β1-induced Collagen Expression in Epithelial Cells via Increased αvβ3-Integrin and Rac1 Activity* , 2010, The Journal of Biological Chemistry.

[28]  Kenji Suzuki,et al.  Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy , 2010, Hypertension Research.

[29]  H. Dietz,et al.  Altered TGFβ signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency , 2010, European Journal of Human Genetics.

[30]  D. Judge,et al.  Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome , 2010, Science Translational Medicine.

[31]  Takako Sasaki,et al.  Conditional inactivation of TGF-β type II receptor in smooth muscle cells and epicardium causes lethal aortic and cardiac defects , 2010, Transgenic Research.

[32]  Madhusudhan Budatha,et al.  Fibulin-4 Deficiency Results in Ascending Aortic Aneurysms: A Potential Link Between Abnormal Smooth Muscle Cell Phenotype and Aneurysm Progression , 2010, Circulation research.

[33]  M. Singer,et al.  Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C , 2010, Scandinavian journal of gastroenterology.

[34]  M. Matsuzaki,et al.  Lysyl oxidase resolves inflammation by reducing monocyte chemoattractant protein-1 in abdominal aortic aneurysm. , 2010, Atherosclerosis.

[35]  S. Oparil,et al.  Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart. , 2010, American journal of physiology. Heart and circulatory physiology.

[36]  L. Rénia,et al.  TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. , 2010, The Journal of clinical investigation.

[37]  Ankoor S. Shah,et al.  Thoracic endografting in a patient with hereditary hemorrhagic telangiectasia presenting with a descending thoracic aneurysm. , 2010, Journal of vascular surgery.

[38]  H. Dietz.  TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. , 2010, The Journal of clinical investigation.

[39]  A. Sonnenberg,et al.  Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing , 2010, EMBO reports.

[40]  C. Boileau,et al.  Dermal tissue and cellular expression of fibrillin-1 in diffuse cutaneous systemic sclerosis. , 2010, Rheumatology.

[41]  Gene Kim,et al.  S100A12 Mediates Aortic Wall Remodeling and Aortic Aneurysm , 2010, Circulation research.

[42]  B. Hinz,et al.  The myofibroblast: paradigm for a mechanically active cell. , 2010, Journal of biomechanics.

[43]  D. Milewicz,et al.  An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. , 2009, The Journal of clinical investigation.

[44]  K. Holland,et al.  Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development. , 2009, American journal of human genetics.

[45]  F. Alkuraya,et al.  Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. , 2009, American journal of human genetics.

[46]  Takeshi Kimura,et al.  Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Beasley,et al.  Simvastatin Inhibits Angiotensin II–Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E–Knockout Mice: Possible Role of ERK , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[48]  C. Heldin,et al.  The regulation of TGFβ signal transduction , 2009, Development.

[49]  C. van Breemen,et al.  Long‐term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome , 2009, British journal of pharmacology.

[50]  S. Nishimura.  Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. , 2009, The American journal of pathology.

[51]  S. Apte.  A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and Mechanisms* , 2009, The Journal of Biological Chemistry.

[52]  H. Dietz,et al.  Circulating Transforming Growth Factor-&bgr; in Marfan Syndrome , 2009, Circulation.

[53]  D. Mackey,et al.  Null mutations in LTBP2 cause primary congenital glaucoma. , 2009, American journal of human genetics.

[54]  A. Noor,et al.  Oligodontia is caused by mutation in LTBP3, the gene encoding latent TGF-beta binding protein 3. , 2009, American journal of human genetics.

[55]  B. Pasche,et al.  Transforming growth factor β as a therapeutic target in systemic sclerosis , 2009, Nature Reviews Rheumatology.

[56]  C. Streuli,et al.  Signal co-operation between integrins and other receptor systems. , 2009, The Biochemical journal.

[57]  H. Dietz,et al.  p38 MAPK Is an Early Determinant of Promiscuous Smad2/3 Signaling in the Aortas of Fibrillin-1 (Fbn1)-null Mice* , 2009, Journal of Biological Chemistry.

[58]  S. Leal,et al.  A homozygous mutation in ADAMTSL4 causes autosomal-recessive isolated ectopia lentis. , 2009, American journal of human genetics.

[59]  V. Kaartinen,et al.  Absence of TGFβ signaling in embryonic vascular smooth muscle leads to reduced lysyl oxidase expression, impaired elastogenesis, and aneurysm , 2009, Genesis.

[60]  K. Csiszȧr,et al.  Lysyl Oxidase Binds Transforming Growth Factor-β and Regulates Its Signaling via Amine Oxidase Activity* , 2008, Journal of Biological Chemistry.

[61]  W. Schiemann,et al.  Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. , 2008, Carcinogenesis.

[62]  M. McKee,et al.  Fibrillin assembly requires fibronectin. , 2008, Molecular biology of the cell.

[63]  J. Jones,et al.  Integrin Cross-talk in Endothelial Cells Is Regulated by Protein Kinase A and Protein Phosphatase 1* , 2008, Journal of Biological Chemistry.

[64]  Alcino J. Silva,et al.  Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning , 2008, Cell.

[65]  M. Yamashita,et al.  TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. , 2008, Molecular cell.

[66]  B. Hinz,et al.  Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. , 2008, European journal of cell biology.

[67]  A. Munnich,et al.  ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-β bioavailability regulation , 2008, Nature Genetics.

[68]  Tomoki Nakamura,et al.  Genetic approaches for changing the heart and dissecting complex syndromes. , 2008, Journal of molecular and cellular cardiology.

[69]  D. Clapp,et al.  Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway. , 2008, Human molecular genetics.

[70]  M. Radomski,et al.  Long-Term Doxycycline Is More Effective Than Atenolol to Prevent Thoracic Aortic Aneurysm in Marfan Syndrome Through the Inhibition of Matrix Metalloproteinase-2 and -9 , 2008, Circulation research.

[71]  F. Martinez,et al.  An essential role for fibronectin extra type III domain A in pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.

[72]  Takako Sasaki,et al.  Compound heterozygous mutations in fibulin‐4 causing neonatal lethal pulmonary artery occlusion, aortic aneurysm, arachnodactyly, and mild cutis laxa , 2007, American journal of medical genetics. Part A.

[73]  D. Milewicz,et al.  MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. , 2007, Human molecular genetics.

[74]  A. Dart,et al.  Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. , 2007, JAMA.

[75]  S. Colan,et al.  Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. , 2007, American heart journal.

[76]  M. Farach-Carson,et al.  Potential Role for Heparan Sulfate Proteoglycans in Regulation of Transforming Growth Factor-β (TGF-β) by Modulating Assembly of Latent TGF-β-binding Protein-1* , 2007, Journal of Biological Chemistry.

[77]  Jing Qing,et al.  TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA , 2007 .

[78]  P. Morin,et al.  Filamin A-mediated Down-regulation of the Exchange Factor Ras-GRF1 Correlates with Decreased Matrix Metalloproteinase-9 Expression in Human Melanoma Cells* , 2007, Journal of Biological Chemistry.

[79]  D. Judge,et al.  Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states , 2007, Nature Medicine.

[80]  H. Dietz,et al.  Perturbations of Vascular Homeostasis and Aortic Valve Abnormalities in Fibulin-4 Deficient Mice , 2007, Circulation research.

[81]  P. Byers,et al.  Aneurysm syndromes caused by mutations in the TGF-beta receptor. , 2006, The New England journal of medicine.

[82]  George H. Thomas,et al.  Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .

[83]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[84]  H. Dietz,et al.  Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome , 2006, Nature Genetics.

[85]  S. Dupont,et al.  Emilin1 Links TGF-β Maturation to Blood Pressure Homeostasis , 2006, Cell.

[86]  L. Maile,et al.  Insulin-like growth factor-i signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the β3-subunit of αVβ3 , 2006 .

[87]  A. Lalande,et al.  Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus , 2006, Nature Genetics.

[88]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[89]  M. Jinnin,et al.  Increased Expression of Integrin αvβ3 Contributes to the Establishment of Autocrine TGF-β Signaling in Scleroderma Fibroblasts1 , 2005, The Journal of Immunology.

[90]  R. Ricci,et al.  Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase , 2005, Nature Medicine.

[91]  M. Cinelli,et al.  Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study. , 2005, The Journal of rheumatology.

[92]  M. Jinnin,et al.  Involvement of αvβ5 integrin–mediated activation of latent transforming growth factor β1 in autocrine transforming growth factor β signaling in systemic sclerosis fibroblasts , 2005 .

[93]  S. Shete,et al.  Mutations in Transforming Growth Factor-&bgr; Receptor Type II Cause Familial Thoracic Aortic Aneurysms and Dissections , 2005, Circulation.

[94]  K. Csiszȧr,et al.  Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis , 2005, Arthritis research & therapy.

[95]  J. Qin,et al.  VEGF-integrin interplay controls tumor growth and vascularization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[96]  J. Egido,et al.  Angiotensin II Activates the Smad Pathway in Vascular Smooth Muscle Cells by a Transforming Growth Factor-β–Independent Mechanism , 2005, Circulation.

[97]  B. McCrindle,et al.  Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. , 2005, The American journal of cardiology.

[98]  M. Humphries,et al.  Fibronectin Regulates Latent Transforming Growth Factor-β (TGFβ) by Controlling Matrix Assembly of Latent TGFβ-binding Protein-1* , 2005, Journal of Biological Chemistry.

[99]  C. Walsh,et al.  Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome , 2005, Neurology.

[100]  S. Belmadani,et al.  Involvement of Metalloproteinases 2/9 in Epidermal Growth Factor Receptor Transactivation in Pressure-Induced Myogenic Tone in Mouse Mesenteric Resistance Arteries , 2004, Circulation.

[101]  D. Judge,et al.  TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome , 2004 .

[102]  A. Munnich,et al.  ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome. , 2004, American journal of human genetics.

[103]  M. Black,et al.  Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade. , 2004, Journal of molecular and cellular cardiology.

[104]  P. De Camilli,et al.  Competition for Talin Results in Trans-dominant Inhibition of Integrin Activation* , 2004, Journal of Biological Chemistry.

[105]  W. Schiemann,et al.  Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. , 2004, DNA and cell biology.

[106]  Yusuke Nakamura,et al.  Heterozygous TGFBR2 mutations in Marfan syndrome , 2004, Nature Genetics.

[107]  P. Thompson,et al.  αvβ3 Integrin Interacts with the Transforming Growth Factor β (TGFβ) Type II Receptor to Potentiate the Proliferative Effects of TGFβ1 in Living Human Lung Fibroblasts* , 2004, Journal of Biological Chemistry.

[108]  K. Holman,et al.  Ectopia lentis phenotypes and the FBN1 gene , 2004, American journal of medical genetics. Part A.

[109]  N. Yorioka,et al.  Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-β1 , 2004 .

[110]  L. Sheils,et al.  Large aneurysms of the ascending aorta and major coronary arteries in a patient with hereditary hemorrhagic telangiectasia. , 2003, Mayo Clinic proceedings.

[111]  A. Yoshimura,et al.  Oncostatin M, an Interleukin-6 Family Cytokine, Upregulates Matrix Metalloproteinase-9 Through the Mitogen-Activated Protein Kinase Kinase-Extracellular Signal-Regulated Kinase Pathway in Cultured Smooth Muscle Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[112]  D. Arking,et al.  Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.

[113]  D. Rifkin,et al.  Latent Transforming Growth Factor β-binding Protein 1 Interacts with Fibrillin and Is a Microfibril-associated Protein* , 2003, The Journal of Biological Chemistry.

[114]  A. Munnich,et al.  In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome , 2003, Journal of medical genetics.

[115]  J. Otte,et al.  Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. , 2002, Genes & development.

[116]  S. Rosenkranz,et al.  Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1 , 2002 .

[117]  H. Lodish,et al.  Context-specific Effects of Fibulin-5 (DANCE/EVEC) on Cell Proliferation, Motility, and Invasion , 2002, The Journal of Biological Chemistry.

[118]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[119]  H. Koyanagi,et al.  Angiotensin II Type 2 Receptor Mediates Vascular Smooth Muscle Cell Apoptosis in Cystic Medial Degeneration Associated With Marfan’s Syndrome , 2001, Circulation.

[120]  K. Ikeda,et al.  Filamin Associates with Smads and Regulates Transforming Growth Factor-β Signaling* , 2001, The Journal of Biological Chemistry.

[121]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[122]  N. Fukuda,et al.  Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells. , 2000, American journal of hypertension.

[123]  C. H. Conrad,et al.  Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice , 2000 .

[124]  G. Wolf,et al.  Angiotensin II stimulates expression of transforming growth factor β receptor type II in cultured mouse proximal tubular cells , 1999, Journal of Molecular Medicine.

[125]  D. Milewicz,et al.  Fibrillin–2 (FBN2) mutations result in the Marfan–like disorder, congenital contractural arachnodactyly , 1995, Nature Genetics.

[126]  A. Everett,et al.  Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. , 1994, Hypertension.

[127]  J. Stockman,et al.  Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice , 2012 .

[128]  H. Dietz,et al.  Fibrosis: Insights from the Stiff Skin Syndrome , 2012 .

[129]  H. Dietz,et al.  Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome , 2011, Cell and Tissue Research.

[130]  J. Stockman,et al.  Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome , 2010 .

[131]  Gregory J. Hardy,et al.  Interferon- (cid:1) and the Interferon-Inducible Chemokine CXCL10 Protect Against Aneurysm Formation and Rupture Molecular Cardiology , 2009 .

[132]  B. Baxter,et al.  Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome. , 2008, Journal of vascular surgery.

[133]  Vijay G Divakaran,et al.  Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. , 2008, Basic research in cardiology.

[134]  M. Farach-Carson,et al.  Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by modulating assembly of latent TGF-beta-binding protein-1. , 2007, The Journal of biological chemistry.

[135]  Jing Qing,et al.  TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. , 2007, The EMBO journal.

[136]  Robert K. Yu,et al.  Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections (vol 39, pg 1488, 2007) , 2008 .

[137]  Vijay G Divakaran,et al.  Transforming growth factor-β receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor , 2007, Basic Research in Cardiology.

[138]  永田 剛.  Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells , 2007 .

[139]  M. Jinnin,et al.  Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts. , 2005, Arthritis and rheumatism.

[140]  M. Jinnin,et al.  Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. , 2005, Journal of immunology.

[141]  M. Humphries,et al.  Fibronectin regulates latent transforming growth factor-beta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1. , 2005, The Journal of biological chemistry.

[142]  D. Judge,et al.  TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. , 2004, The Journal of clinical investigation.

[143]  N. Yorioka,et al.  Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. , 2004, American journal of physiology. Renal physiology.

[144]  P. Thompson,et al.  alpha(v)beta(3) Integrin interacts with the transforming growth factor beta (TGFbeta) type II receptor to potentiate the proliferative effects of TGFbeta1 in living human lung fibroblasts. , 2004, The Journal of biological chemistry.

[145]  J. Huot,et al.  Integrin αvβ3 requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF , 2003, Cell stress & chaperones.

[146]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[147]  D. Arking,et al.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. , 2003, Nature genetics.

[148]  A. Takeshita,et al.  Transforming Growth Factor- (cid:1) Function Blocking Prevents Myocardial Fibrosis and Diastolic Dysfunction in Pressure-Overloaded Rats , 2002 .

[149]  S. Rosenkranz,et al.  Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). , 2002, American journal of physiology. Heart and circulatory physiology.

[150]  D. Marchuk,et al.  Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. , 2000, Developmental biology.

[151]  C. H. Conrad,et al.  Myocardial fibrosis in transforming growth factor beta(1)heterozygous mice. , 2000, Journal of molecular and cellular cardiology.

[152]  R. Mecham,et al.  Remodeling of elastic fiber components in scleroderma skin. , 1999, Connective tissue research.

[153]  G. Wolf,et al.  Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. , 1999, Journal of molecular medicine.